Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1958 1
1972 1
1976 1
1977 1
1979 1
1980 1
1981 3
1982 3
1983 3
1984 11
1985 8
1986 13
1987 17
1988 9
1989 15
1990 17
1991 20
1992 34
1993 37
1994 30
1995 42
1996 47
1997 54
1998 68
1999 80
2000 90
2001 96
2002 125
2003 162
2004 172
2005 195
2006 229
2007 274
2008 274
2009 297
2010 399
2011 461
2012 505
2013 631
2014 781
2015 845
2016 911
2017 919
2018 1085
2019 1290
2020 1507
2021 1609
2022 1930
2023 571
Text availability
Article attribute
Article type
Publication date

Search Results

14,181 results
Results by year
Filters applied: . Clear all
Page 1
Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion.
Tao C, Nogueira RG, Zhu Y, Sun J, Han H, Yuan G, Wen C, Zhou P, Chen W, Zeng G, Li Y, Ma Z, Yu C, Su J, Zhou Z, Chen Z, Liao G, Sun Y, Ren Y, Zhang H, Chen J, Yue X, Xiao G, Wang L, Liu R, Liu W, Liu Y, Wang L, Zhang C, Liu T, Song J, Li R, Xu P, Yin Y, Wang G, Baxter B, Qureshi AI, Liu X, Hu W; ATTENTION Investigators. Tao C, et al. Among authors: hu w. N Engl J Med. 2022 Oct 13;387(15):1361-1372. doi: 10.1056/NEJMoa2206317. N Engl J Med. 2022. PMID: 36239644 Clinical Trial.
Laparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial.
Huang C, Liu H, Hu Y, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Yu J, Zheng C, Liu F, Li Z, Zhao G, Zhang J, Chen P, Li G; Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group. Huang C, et al. Among authors: hu w. JAMA Surg. 2022 Jan 1;157(1):9-17. doi: 10.1001/jamasurg.2021.5104. JAMA Surg. 2022. PMID: 34668963 Free PMC article. Clinical Trial.
Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial.
Liu X, Dai Q, Ye R, Zi W, Liu Y, Wang H, Zhu W, Ma M, Yin Q, Li M, Fan X, Sun W, Han Y, Lv Q, Liu R, Yang D, Shi Z, Zheng D, Deng X, Wan Y, Wang Z, Geng Y, Chen X, Zhou Z, Liao G, Jin P, Liu Y, Liu X, Zhang M, Zhou F, Shi H, Zhang Y, Guo F, Yin C, Niu G, Zhang M, Cai X, Zhu Q, Chen Z, Liang Y, Li B, Lin M, Wang W, Xu H, Fu X, Liu W, Tian X, Gong Z, Shi H, Wang C, Lv P, Tao Z, Zhu L, Yang S, Hu W, Jiang P, Liebeskind DS, Pereira VM, Leung T, Yan B, Davis S, Xu G, Nogueira RG; BEST Trial Investigators. Liu X, et al. Among authors: hu w. Lancet Neurol. 2020 Feb;19(2):115-122. doi: 10.1016/S1474-4422(19)30395-3. Epub 2019 Dec 9. Lancet Neurol. 2020. PMID: 31831388 Clinical Trial.
Pectin in Metabolic Liver Disease.
Hu W, Cassard AM, Ciocan D. Hu W, et al. Nutrients. 2022 Dec 29;15(1):157. doi: 10.3390/nu15010157. Nutrients. 2022. PMID: 36615814 Free PMC article. Review.
[No title available]
Jia W, Wei L, Li J, Xia B, Zeng X, Hu W, Zhang Y, Liu F. Jia W, et al. Among authors: hu w. Altern Ther Health Med. 2023 Mar 7:AT7981. Online ahead of print. Altern Ther Health Med. 2023. PMID: 36881537 Free article.
Liver injury in COVID-19: A minireview.
Hu WS, Jiang FY, Shu W, Zhao R, Cao JM, Wang DP. Hu WS, et al. World J Gastroenterol. 2022 Dec 21;28(47):6716-6731. doi: 10.3748/wjg.v28.i47.6716. World J Gastroenterol. 2022. PMID: 36620342 Free PMC article. Review.
Mesangial cell: A hub in lupus nephritis.
Liu M, Zhang L, Wang Y, Hu W, Wang C, Wen Z. Liu M, et al. Among authors: hu w. Front Immunol. 2022 Dec 14;13:1063497. doi: 10.3389/fimmu.2022.1063497. eCollection 2022. Front Immunol. 2022. PMID: 36591251 Free PMC article. Review.
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Zhu HD, Li HL, Huang MS, Yang WZ, Yin GW, Zhong BY, Sun JH, Jin ZC, Chen JJ, Ge NJ, Ding WB, Li WH, Huang JH, Mu W, Gu SZ, Li JP, Zhao H, Wen SW, Lei YM, Song YS, Yuan CW, Wang WD, Huang M, Zhao W, Wu JB, Wang S, Zhu X, Han JJ, Ren WX, Lu ZM, Xing WG, Fan Y, Lin HL, Zhang ZS, Xu GH, Hu WH, Tu Q, Su HY, Zheng CS, Chen Y, Zhao XY, Fang ZT, Wang Q, Zhao JW, Xu AB, Xu J, Wu QH, Niu HZ, Wang J, Dai F, Feng DP, Li QD, Shi RS, Li JR, Yang G, Shi HB, Ji JS, Liu YE, Cai Z, Yang P, Zhao Y, Zhu XL, Lu LG, Teng GJ; CHANCE001 Investigators. Zhu HD, et al. Among authors: hu wh. Signal Transduct Target Ther. 2023 Feb 8;8(1):58. doi: 10.1038/s41392-022-01235-0. Signal Transduct Target Ther. 2023. PMID: 36750721 Free PMC article.
14,181 results
You have reached the last available page of results. Please see the User Guide for more information.